NCT07046715View on ClinicalTrials.gov

Clinical Trial Comparing Single-administration of DA-5222 and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects in Fed State

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

August 31, 2025

Study Completion Date

September 30, 2025

Conditions
Healthy
Interventions
DRUG

DA-5222

single dose administration (DA-5222 one tablet once a day)

DRUG

DA-5222-R1

single dose administration (DA-5222-R1 one tablet once a day)

DRUG

DA-5222-R2

single dose administration (DA-5222-R2 one tablet once a day)

DRUG

DA-5222-R3

single dose administration (DA-5222-R3 one tablet once a day)

All Listed Sponsors
lead

Dong-A ST Co., Ltd.

INDUSTRY